Marketing

Sugary Deals Tempt Health Care Charities

Public health charities are under intense pressure from potential or ongoing commercial sponsors to boost their budgets with product promotion schemes. For example, the American Diabetes Association (ADA) currently has a $1.5 million sponsorship deal with Cadbury Schweppes, maker of Dr. Pepper and the Cadbury Creme egg.

Implant Flacks

On November 17 the U.S. Food and Drug Administration (FDA) approved silicone breast implants manufactured by Mentor Corporation and Allergan. PR Week reports that the PR firm MS&L "began working with Inamed Corp.

Big Pharma Poised to Pay For Faster FDA Ad Approval

Negotiators representing Big Pharma and the U.S. Food and Drug Administration are close to a deal on raising fees paid by industry to speed up reviews of direct-to-consumer advertising. A spokesperson for the trade group BioCentury said that the FDA is seeking to raise about $6.2 million per year, putting individual application review fees at about $41,000.

Drug Industry's Glory Days May Be Over

The drug industry is bracing itself for major legislative changes once the new Congress sits. Forbes journalist Matthew Herper notes that, following the mid-term elections, major drug company shares have dropped by over 5%.

U.S. Fake News Sales Slide

One indication that the controversy over the unattributed use of video news releases (VNRs) is beginning to bite is buried in the latest quarterly financial report of Medialink Worldwide, the $30 million a year behemoth of the fake news industry.

FCC Commissioners Pledge Expanded Inquiry Into Fake News

Federal Communication Commissioners (FCC) Michael Copps and Jonathan Adelstein have promised an investigation into each of the 46 television stations revealed by the Center for Media and Democracy's report, Still Not the News to have used undisclosed

U.S. Lobbies Against U.K. Drug System

US Deputy Health Secretary, Alex Azar, is lobbying the Britain's Health Secretary, Patricia Hewitt, to ease restrictions on the drug industry. In particular, the U.S. drug companies want the ban on direct-to-consumer advertising dropped and to increase the prices the government pays for drugs.

Drugging Kids

Even though the European Medicines Agency has endorsed the use of Prozac and similar drugs in children over eight, medical researchers doubt the appropriateness of prescribing such powerful drugs in all but rare cases.

Hyping Heart Attacks

Alan Cassels notes that disease mongering advertisements for cholesterol-lowering drugs, such as for Pfizer's Lipitor, hype the risk of heart attacks for those people with 'high' cholesterol.

Spin Doctors and Spun Bioethics

The Eli Lilly drug company used the Belsito & Company PR firm in its deceptive marketing campaign to promote Xigris, its drug for treatment of sepsis.

Syndicate content